Intensity-modulated radiation therapy of anal squamous cell carcinoma: Relationship between delineation quality and regional recurrence

Radiotherapy and Oncology - Tập 131 - Trang 93-100 - 2019
Nathalie Rouard1, Didier Peiffert1, Emmanuel Rio2, Marc-André Mahé2, Gregory Delpon2, Vincent Marchesi1, Alexander T. Falk1,3, Julia Salleron4, Anne-Agathe Serre1
1Département de Radiothérapie, Institut de Cancérologie de Lorraine, Vandoeuvre-Les-Nancy, France
2Département de Radiothérapie, Institut de Cancérologie de l’Ouest, Saint-Herblain, France
3Département de radiothérapie, Centre Antoine Lacassagne, Nice, France
4Cellule Data-biostatistiques, Institut de Cancérologie de Lorraine, Université de Lorraine, Vandœuvre-lès-Nancy, France

Tài liệu tham khảo

Northover, 2010, Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I), Br J Cancer, 102, 1123, 10.1038/sj.bjc.6605605 Bartelink, 1997, J Clin Oncol, 15, 2040, 10.1200/JCO.1997.15.5.2040 Flam, 1996, Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study, J Clin Oncol, 14, 2527, 10.1200/JCO.1996.14.9.2527 Gunderson, 2012, Long-term update of US GI intergroup RTOG 98–11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin, J Clin Oncol, 30, 4344, 10.1200/JCO.2012.43.8085 James, 2013, Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial, Lancet Oncol, 14, 516, 10.1016/S1470-2045(13)70086-X Das, 2007, Predictors and patterns of recurrence after definitive chemoradiation for anal cancer, Int J Radiat Oncol, 68, 794, 10.1016/j.ijrobp.2006.12.052 Wright, 2010, Squamous cell carcinoma of the anal canal: patterns and predictors of failure and implications for intensity-modulated radiation treatment planning, Int J Radiat Oncol, 78, 1064, 10.1016/j.ijrobp.2009.09.029 Vieillot, 2012, IMRT for locally advanced anal cancer: clinical experience of the Montpellier Cancer Center, Radiat Oncol, 7, 45, 10.1186/1748-717X-7-45 Vendrely, 2015, French multicentre clinical evaluation of helical TomoTherapy® for anal cancer in a cohort of 64 consecutive patients, Radiat Oncol [Internet], 10 Brooks, 2013, Organ-sparing intensity-modulated radiotherapy for anal cancer using the ACTII schedule: a comparison of conventional and intensity-modulated radiotherapy plans, Clin Oncol, 25, 155, 10.1016/j.clon.2012.08.008 Kachnic, 2013, RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-c for the reduction of acute morbidity in carcinoma of the anal canal, Int J Radiat Oncol, 86, 27, 10.1016/j.ijrobp.2012.09.023 Milano, 2005, Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: Toxicity and clinical outcome, Int J Radiat Oncol, 63, 354, 10.1016/j.ijrobp.2005.02.030 Chen, 2005, Organ sparing by conformal avoidance intensity-modulated radiation therapy for anal cancer: Dosimetric evaluation of coverage of pelvis and inguinal/femoral nodes, Int J Radiat Oncol, 63, 274, 10.1016/j.ijrobp.2005.05.052 Chuong, 2013, Radiation therapy vs. 3d conformal radiation therapy for squamous cell carcinoma of the anal canal, Gastrointest Cancer Res, 6, 39 Cannon, 2008, Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer, Int J Radiat Oncol, 70, 660, 10.1016/j.ijrobp.2007.09.018 Eisbruch, 2004, Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing, Int J Radiat Oncol, 59, 28, 10.1016/j.ijrobp.2003.10.032 Ng, 2012, Australasian Gastrointestinal Trials Group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer, Int J Radiat Oncol, 83, 1455, 10.1016/j.ijrobp.2011.12.058 Myerson, 2009, Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas, Int J Radiat Oncol, 74, 824, 10.1016/j.ijrobp.2008.08.070 Azria D. RCMI canal anal. In: Site Internat de radioanatomie et d’autoenseignement à la délinéation (SIRIADE). Paris: Afcor,SFRO,SFJRO [Internet]. 2011; Available from: www.siriade.org. Dasgupta, 2013, Intensity-modulated radiotherapy vs. conventional radiotherapy in the treatment of anal squamous cell carcinoma: A propensity score analysis, Radiother Oncol, 107, 189, 10.1016/j.radonc.2013.03.012 Cordoba, 2017, Low-dose-rate interstitial brachytherapy boost for the treatment of anal canal cancers, Brachytherapy, 16, 230, 10.1016/j.brachy.2016.07.007 Hannoun-Levi, 2011, High-dose split-course radiation therapy for anal cancer: outcome analysis regarding the boost strategy (CORS-03 Study), Int J Radiat Oncol, 80, 712, 10.1016/j.ijrobp.2010.02.055 Damin, 2006, Sentinel lymph node in carcinoma of the anal canal: a review, Eur J Surg Oncol EJSO, 32, 247, 10.1016/j.ejso.2005.08.006 de Jong, 2010, Limited value of staging squamous cell carcinoma of the anal margin and canal using the sentinel lymph node procedure: a prospective study with long-term follow-up, Ann Surg Oncol, 17, 2656, 10.1245/s10434-010-1063-7 Nardi, 2012, New approach to anal cancer: Individualized therapy based on sentinel lymph node biopsy, World J Gastroenterol, 18, 6349, 10.3748/wjg.v18.i44.6349 Tehranian, 2013, Sentinel node mapping in anal canal cancer: systematic review and meta-analysis, J Gastrointestin Liver Dis, 22 Wáng, 2017, A comprehensive literatures update of clinical researches of superparamagnetic resonance iron oxide nanoparticles for magnetic resonance imaging, Quant Imaging Med Surg, 7, 88, 10.21037/qims.2017.02.09 Will, 2006, Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis, Lancet Oncol, 7, 52, 10.1016/S1470-2045(05)70537-4 Wu, 2011, Diagnostic performance of USPIO-enhanced MRI for lymph-node metastases in different body regions: a meta-analysis, Eur J Radiol, 80, 582, 10.1016/j.ejrad.2009.11.027